EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protective Effects of Allicin and Garlic-Derived Interventions Against Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Evidence and Mechanistic Insights

Niuniu Sun, Yongqiang Gao iD, Yu Xing, Mingyang Guo, Xinyu Xu, Jingxi Hu, Zitong He, Jiapeng Luo, Sheng Li iD, Zhaozhao Hui iD, Shunming Zhang iD

Nutrients · 07.08.2026 · 18 (16) · 2596

DOI: 10.3390/nu18162596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 07.08.2026. Verfasst von Niuniu Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Henan University of Science and Technology, Luoyang 471003, China. Hauptthemen laut MEDLINE: Garlic, Sulfinic Acids, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Basic Research Project of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide and poses a significant public health challenge. Allicin, a major bioactive organosulfur compound derived from garlic, has emerged as a promising candidate for MASLD prevention and management due to its antioxidant, anti-inflammatory, and metabolic regulatory properties. Despite its potential, evidence regarding allicin’s efficacy on MASLD remains limited and heterogeneous because existing studies have evaluated different garlic-derived interventions across diverse experimental settings. This review therefore distinguishes studies of purified allicin from those of raw garlic, garlic powder, aged garlic extract, black garlic, garlic essential oil, and individual garlic compounds. Preclinical studies using allicin suggest beneficial effects on hepatic steatosis, inflammation, glucose homeostasis, and lipid metabolism. Human studies, however, have evaluated raw garlic consumption or garlic powder supplementation rather than allicin alone. Findings from other garlic preparations and individual compounds are attributed only to the intervention tested, because differences in composition, stability, bioavailability, metabolism, and pharmacological activity preclude their attribution to allicin. Moreover, the available clinical trial evidence comprises five publications derived from only two randomized controlled trials conducted in Iran, both lasting 12–15 weeks. In addition, preclinical evidence most consistently supports regulation of hepatic lipid metabolism, particularly the AMP-activated protein kinase/sterol regulatory element-binding protein-1c-related signaling, as a potential mechanism underlying the anti-steatotic effects of allicin. Additional pathways may involve inflammatory signaling, oxidative stress, gut microbiota, and bile acid-related regulation, although the evidence for several of these mechanisms remains suggestive. Nevertheless, the precise molecular targets and signaling networks underlying these effects remain incompletely understood, and the relevance of allicin to aging-related MASLD is largely unexplored because previous studies have used young animals. Future studies should incorporate aged models and long-term randomized controlled trials across diverse populations to clarify the mechanisms, therapeutic potential, and safety of allicin in MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GarlicSulfinic AcidsFatty LiverMetabolic DiseasesNon-alcoholic Fatty Liver DiseaseDisulfidesHumansAnimalsAntioxidantsLiverLipid MetabolismPlant ExtractsDietary Supplements

Stichwörter der Autor:innen

allicingarlicmetabolic dysfunction-associated steatotic liver diseasenon-alcoholic fatty liver diseasereview

Substanzen

allicinDisulfidesSulfinic AcidsAntioxidantsPlant Extracts

Autor:innen und Institutionen

  • School of Nursing, Henan University of Science and Technology, Luoyang 471003, China.
  • School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.

ORCID-Profile: Yongqiang Gao, Sheng Li, Zhaozhao Hui, Shunming Zhang

Förderung

  • Natural Science Basic Research Project of Shaanxi Province

Zitieren

APA

Sun, N., Gao, Y., Xing, Y., Guo, M., Xu, X., Hu, J., He, Z., Luo, J., Li, S., Hui, Z., & Zhang, S. (2026). Protective Effects of Allicin and Garlic-Derived Interventions Against Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Evidence and Mechanistic Insights. Nutrients, 18(16), 2596. https://doi.org/10.3390/nu18162596

Vancouver

Sun N, Gao Y, Xing Y, Guo M, Xu X, Hu J, et al. Protective Effects of Allicin and Garlic-Derived Interventions Against Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Evidence and Mechanistic Insights. Nutrients. 2026;18(16):2596. doi:10.3390/nu18162596

BibTeX
@article{Sun2026,
  author = {Sun, Niuniu and Gao, Yongqiang and Xing, Yu and Guo, Mingyang and Xu, Xinyu and Hu, Jingxi and He, Zitong and Luo, Jiapeng and Li, Sheng and Hui, Zhaozhao and Zhang, Shunming},
  title = {Protective Effects of Allicin and Garlic-Derived Interventions Against Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Evidence and Mechanistic Insights},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {2596},
  doi = {10.3390/nu18162596}
}
Kostenlos starten →